Letermovir Not Yet Recruiting Phase 2 Trials for Cytomegalovirus (CMV) Infection Prevention

IndicationsStatusPurposePhase
Not Yet RecruitingPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT03940586Letermovir Treatment in Pediatric Participants Following Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) (MK-8228-030)